Loading...
CRS1 logo

Ercros, S.A.DB:CRS1 Stock Report

Market Cap €311.8m
Share Price
€3.41
€1.21
180.9% overvalued intrinsic discount
1Y13.7%
7D0.4%
Portfolio Value
View

Ercros, S.A.

DB:CRS1 Stock Report

Market Cap: €311.8m

Ercros (CRS1) Stock Overview

Manufactures and sells chemical and pharmaceutical products in Spain and internationally. More details

CRS1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

CRS1 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Community Contributor
CA$5.07FV 70.4% undervalued intrinsic discount
4849.4%Revenue growth p.a.
12.5k
37
1
251
2mo ago

Ercros, S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ercros
Historical stock prices
Current Share Price€3.41
52 Week High€3.56
52 Week Low€2.21
Beta0.27
1 Month Change0.15%
3 Month Change-0.15%
1 Year Change13.67%
3 Year Change-18.81%
5 Year Change28.68%
Change since IPO-61.71%

Recent News & Updates

Recent updates

Shareholder Returns

CRS1DE ChemicalsDE Market
7D0.4%1.6%-2.8%
1Y13.7%5.8%3.7%

Return vs Industry: CRS1 exceeded the German Chemicals industry which returned 5.9% over the past year.

Return vs Market: CRS1 exceeded the German Market which returned 3.7% over the past year.

Price Volatility

Is CRS1's price volatile compared to industry and market?
CRS1 volatility
CRS1 Average Weekly Movement4.4%
Chemicals Industry Average Movement5.6%
Market Average Movement6.0%
10% most volatile stocks in DE Market13.7%
10% least volatile stocks in DE Market2.6%

Stable Share Price: CRS1 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: CRS1's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18171,329Joao Maria Guimaraes Jose Mellowww.ercros.es

Ercros, S.A., together with its subsidiaries, manufactures and sells chemical and pharmaceutical products in Spain and internationally. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The company offers ammonia, caustic soda and potash, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride.

Ercros, S.A. Fundamentals Summary

How do Ercros's earnings and revenue compare to its market cap?
CRS1 fundamental statistics
Market cap€311.80m
Earnings (TTM)-€53.58m
Revenue (TTM)€628.69m
0.5x
P/S Ratio
-5.8x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRS1 income statement (TTM)
Revenue€628.69m
Cost of Revenue€454.24m
Gross Profit€174.45m
Other Expenses€228.03m
Earnings-€53.58m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.59
Gross Margin27.75%
Net Profit Margin-8.52%
Debt/Equity Ratio73.4%

How did CRS1 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/26 01:01
End of Day Share Price 2026/04/24 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ercros, S.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruno BessaCaixa Banco BPI
Alfredo Echevarria OteguiLighthouse-IEAF Servicios de Analisis
Pablo RiveraLighthouse-IEAF Servicios de Analisis